Strategic realignment in Biotech

Original price was: € 199,00.Current price is: € 0,00.


This report reveals the massive opportunities of the life sciences industry in emergent and emerging markets of asia, latin america, and africa. The industry is changing dramatically in a cost-saving and agile way, while still maintaing healthcare standards. For investors, there are many business specific opportunities. This questionnaire touches on various aspects of strategic realignment (and not only for Biotech).

SKU: c660af20-a915-4894-9ba9-fccf9b38a6b5 Category: Tags: , , , , , , , , , , , , , , , , , , ,
Available in: English, Dutch, French, German, Spanish
  • The manager with a very poor return on investment ratio.
  • The chief strategy officer who needs to draw up a strategic plan.
  • The CTO who needs to realign the organization's strategic road map.
  • The managing partner who needs to advise her client on strategy matters.
  • The Chief innovation officer who is requested to set out a new course.
Start with the end in mind
focus on outcomes

Innovation is a process
think about how to innovate

Build an innovation pipeline
develop new products and services

Be prepared for failure
know what not to do when you fail

As you can see, you're not asking your respondents for opinions, satisfaction or agreement. Our scientific research has shown that these are very bad fuel for algorithms. Instead, we ask for verifiable facts or -behaviour. For further reading, you can download our AMAIZE magazine dedicated to this topic or discover the scientific papers in the Resources section.

After you have downloaded this questionnaire, you can - in your Toolbox - edit, add/delete, and translate questions & answers to your liking. Clicking the "Help me PRAIORITIZE" buttons in the Toolbox activates our A.I. to help you finish your masterpiece..

Q. Is there an overall strategy for growth and market development?
  1. Not or only vaguely
  2. Ad hoc growth and marketing plans are drawn up for certain products/markets/regions
  3. An overall growth strategy is elaborated together with a plan of actions and budget allocations

Q. Are target markets (core customers) identified and/or described?
  1. No or only to a limited extent
  2. Identified and described but only used for certain products
  3. Identified and described for all products
The artificial intelligence creating the questionnaires for the store has been inspired by over 11.000 whitepapers from more than 100 noted consultancy firms. Algorithms selected the 20% best papers and grouped papers from different consultancy firms into specific questionnaires. Why settle for less? Here is a summary how we did it.

If you feel you need outside support after conducting your assessment, we recommend the firms that have written the below mentioned whitepapers. Not having a paper selected does NOT mean that a firm does not give good advice.
You will download so much more than a set of questions and answers. This questionnaire contains everything for the full consultancy experience:
  • Respondent profiles for a helicopter view of your audience.
  • A maturity model with which algorithms calculate a six times smarter improvement target (compared to when you leave that to a human).
  • Improvement suggestions (per question) how to move from one answer to another
  • Suggested follow-on projects. After all, moving your organization from A to B might require more than just doing an assessment.
This English questionnaire is also available in Dutch, French, German, and Spanish.


    There are no reviews yet.

    Be the first to review “Strategic realignment in Biotech”

    Your email address will not be published. Required fields are marked *